LHX vs OSIS: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
LHX is the larger of the two ($51.23B market cap): the incumbent the market prices for continued execution (20.19x forward earnings, beta 0.46). OSIS is the smaller challenger ($3.12B), cheaper on forward earnings (15.43x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
LHX vs OSIS: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | LHX | OSIS | What it tells you |
|---|---|---|---|
| Market cap | $51.23B | $3.12B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 20.19 | 15.43 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 25.62 | 21.31 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.46 | 1.26 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 29% of range | 9% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 2.53 | 3.98 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: OSIS is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how LHX and OSIS affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. LHX and OSIS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined LHX and OSIS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does L3Harris Technologies (LHX) do?
L3Harris Technologies is a major US defense and aerospace contractor formed by the 2019 merger of L3 Technologies and Harris Corporation. It positions itself as an agile defense-technology company spanning communications, sensors, electronic warfare, space, intelligence, and missile systems. The business is organized into segments covering Space and Airborne Systems (avionics, sensors, electronic warfare, space payloads), Integrated Mission Systems (ISR, maritime, electro-optical), Communication Systems (tactical radios, secure communications), and, following its acquisition of Aerojet Rocketdyne, a propulsion segment that makes rocket motors and missile propulsion for the US military and space programs. L3Harris primarily sells to the US Department of Defense, allied governments, and intelligence agencies under long-term contracts, which gives it durable, often multi-year revenue backed by defense budgets. It makes money by designing, building, and supporting mission-critical hardware and software, then earning long-tail revenue from sustainment, upgrades, and spare parts. The company also pursues cost-savings programs to expand margins after its large merger and acquisitions. Over the trailing twelve months to mid-2026 it generated about $22.9 billion of revenue (up about 8% year over year in the latest quarter) and about $1.9 billion of net income. In its second quarter of 2026 revenue reached about $5.88 billion and EPS of $3.63 came in well above the roughly $2.84 consensus. In October 2026 it signed a teaming agreement with Divergent Technologies to raise production of lower-cost munitions. Headquartered in Melbourne, Florida, with about 45,000 employees.
What does OSI Systems, Inc. (OSIS) do?
OSI Systems, Inc. runs three divisions from its base in Hawthorne, California, with roughly 7,800 employees. Security is the largest and best known: Rapiscan and AS&E branded X-ray, computed tomography and gamma-ray systems that screen carry-on bags, checked luggage, cargo containers, vehicles and people at airports, ports, borders and government sites, increasingly sold as multi-year turnkey screening services rather than one-off boxes. Healthcare is Spacelabs, which sells patient monitoring, cardiology and anesthesia products into hospitals. Optoelectronics and Manufacturing builds photodiodes, detectors, optical sensors and electronic subassemblies, some for outside customers and some feeding the company's own security and medical products. Fiscal 2026 revenue was about $1.79 billion, up from ~$1.71 billion in fiscal 2025, with net income of ~$155 million and Security contributing roughly two-thirds of the total.
LHX vs OSIS: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- LHX drivers: Rising global defense spending; Diversified mission-critical portfolio.
- OSIS drivers: Aviation and border screening replacement demand; Defense and RF work broadening the mix.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: L3Harris depends heavily on US government and allied defense budgets, so spending cuts, continuing resolutions, government shutdowns, or shifting priorities directly threaten revenue. For OSIS, revenue is concentrated in a small number of very large government contracts, so a single program ending, as the Mexico SEDENA work did, can erase tens of millions of quarterly revenue with little notice; fiscal fourth-quarter revenue fell ~4% year over year and full-year revenue missed guidance.
LHX or OSIS: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick LHX if you believe its drivers more; OSIS if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the LHX and OSIS guides.
LHX vs OSIS: the full fundamentals
LHX. At about $243 a share, L3Harris trades near 24.5 times trailing earnings but about 18 times forward earnings, because analysts expect EPS to keep growing at a low-double-digit pace into 2027. The share price has fallen about 20% in 2026 while earnings rose and the last four quarters all beat estimates, so the multiple has compressed with sector sentiment rather than with the results. The analyst mean target of about $317 sits well above the current price, though several firms trimmed targets in October.
OSIS. Fiscal years end in June, so the trailing figures above are the full fiscal 2026 results. The derating in 2026 has taken OSIS from roughly 22 times guided earnings in August to about 15 times forward estimates now, and from about 2.1 times revenue to ~1.7 times, as the market discounted the revenue miss, margin compression and the Mexico roll-off. Analysts' mean target near $273 sits well above the ~$194 price, so the fiscal first-quarter report (consensus ~$1.65 EPS on ~$396 million revenue) and new bookings matter more to the share price than the headline backlog.
Headline figures (approximate, October 2026): LHX shows revenue (ttm) ~$22.9 billion, revenue growth (latest quarter, yoy) ~8%, operating margin ~12.6%, net income (ttm) ~$1.9 billion; OSIS shows revenue (fiscal 2026, ended june) ~$1.79B (vs ~$1.825B to ~$1.867B guidance), revenue growth (fiscal q4 2026, yoy) ~-4%, net income (fiscal 2026) ~$155M (net margin ~8.7%, operating margin ~14%), p/e (trailing / forward) ~22x / ~15x.
The bottom line: LHX vs OSIS
LHX and OSIS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined LHX and OSIS exposure against your real portfolio. It is not an investment adviser.
Wondering how LHX or OSIS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about L3Harris Technologies
Ask Walnut's AI anything about LHX and see how it fits what you own.
FAQ
What is the difference between LHX and OSIS?
+
L3Harris Technologies is a major US defense and aerospace contractor formed by the 2019 merger of L3 Technologies and Harris Corporation. OSI Systems, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is LHX or OSIS the better stock?
+
Neither is universally better. LHX is the larger incumbent; OSIS is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, LHX or OSIS?
+
On forward P/E (as of November 2026), LHX trades at 20.19x and OSIS at 15.43x, so OSIS is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both LHX and OSIS?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of LHX vs OSIS?
+
LHX: L3Harris depends heavily on US government and allied defense budgets, so spending cuts, continuing resolutions, government shutdowns, or shifting priorities directly threaten revenue. Large fixed-price development programs can run over budget and hurt margins. Integrating major acquisitions like Aerojet Rocketdyne carries execution risk, and the balance sheet carries about $11 billion of debt against about $1.5 billion of cash. Program delays, cost overruns, supply-chain constraints, and procurement protests are recurring risks. Defense stocks can also de-rate on hopes for reduced geopolitical tension, political pressure on the defense budget, or competition from venture-backed entrants such as Anduril, whose private valuation drew attention in October 2026. That de-rating is visible now: LHX is down about 20% in 2026 and about 14% over one year, trading near the bottom of its $232-379 52-week range, and RBC and Bernstein both cut price targets in mid-October. Free cash flow over the trailing year was about $1.6 billion, below operating cash flow of about $3.3 billion. OSIS: Revenue is concentrated in a small number of very large government contracts, so a single program ending, as the Mexico SEDENA work did, can erase tens of millions of quarterly revenue with little notice; fiscal fourth-quarter revenue fell ~4% year over year and full-year revenue missed guidance. Margin direction is the live issue: adjusted operating margin fell about 250 basis points year over year in the fiscal 2026 third quarter even as revenue and EPS beat, and the shares dropped roughly 15% on that report. The stock is down ~24% in 2026 and trades near its 52-week low of ~$186.50. The company has faced repeated allegations around foreign contracts, including a March 2025 Culper Research short report on Mexico revenue recognition and Department of Justice subpoenas, plus an earlier securities case tied to an Albanian concession that was settled; further legal or regulatory action would be a real overhang. Debt of ~$1.05 billion against ~$360 million of cash adds leverage. Share count is small, near 16 million, which makes the per-share price high and daily moves larger than the market cap alone suggests. Competitors including Smiths Detection, Leidos and state-backed Nuctech compete hard on price in international tenders, and government budget timing can push awards across quarters for reasons that have nothing to do with the product.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell LHX or OSIS; figures are approximate and dated (as of November 2026). Verify current data before investing.